首页> 外文OA文献 >Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori
【2h】

Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori

机译:gyrA而不是gyrB中的单突变和双突变与幽门螺杆菌的低水平和高水平氟喹诺酮耐药性相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In one French hospital the rate of resistance to ciprofloxacin in Helicobacter pylori was 3.3% (2 of 60 strains) in 1999. The six resistant clinical strains (four from 1996 and two from 1999) and three ciprofloxacin-selected single-step mutants studied carried one gyrA mutation but none in gyrB. Clinafloxacin and garenoxacin were the most active fluoroquinolones against these mutants. Occurrence of a second gyrA mutation was associated with high MICs of all fluoroquinolones tested.
机译:在一家法国医院中,1999年幽门螺杆菌对环丙沙星的耐药率为3.3%(60株中的2株)。进行了研究的6种耐药菌株(1996年为4株,1999年为2株)和3株环丙沙星选择的单步突变株。一个gyrA突变,但在gyrB中没有。 Clinafloxacin和garenoxacin是针对这些突变体最活跃的氟喹诺酮类。第二个gyrA突变的发生与所有测试的氟喹诺酮类药物的高MIC有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号